Trellus Health plc announced that Non-Executive Chairman, Julian Baines, will stand down from the Board with immediate effect, following the announcement this morning of his appointment as Executive Chairman of EKF Diagnostics Holdings plc. In addition, Dr. Daniel Mahony, Senior Independent Non-Executive Director, will become Non-Executive Chairman with immediate effect. Dan has over 25 years of experience within global healthcare covering biotechnology, medical technology and healthcare services.

Dan was appointed as Entrepreneur-in-Residence at Evotec (UK) Limited in October 2021 and is responsible for the EVOequity investment portfolio. Prior to joining Evotec, he was Co-Head of Healthcare at Polar Capital where he launched the healthcare business in 2007, growing it to over $4 billion of assets under management. Dan was formerly head of European healthcare research at Morgan Stanley, an analyst at ING Barings Furman Selz in New York and a postdoctoral scientist at DNAX Research Institute in Palo Alto.

Dan chairs the Board of the BioIndustry Association (BIA), the industry trade association for UK life sciences, and holds non-executive directorships at the Wellcome Sanger Institute (a world leading genomics research centre), Sernova (a Canadian TSX-listed cell therapy company), Curexsys (a German privately-held biotechnology company) and Keepabl (a UK based, privately-owned provider of SaaS solutions for GDPR compliance). In 2022, he was appointed as the Life Sciences Investment Envoy by the UK Government.